Clinical trial
Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain…
NCT00026494 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00026494 |
|---|---|
| Title | Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases |
| Official title | A Phase I/II Trial Of Temozolomide And Vinorelbine For Patients With Recurrent Brain Metastases |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH Northwestern Memorial Hospital |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Cancer |
| Intervention type | Drug |
| Interventions | temozolomide, vinorelbine tartrate |
| Enrollment | 49 |
| Start date | Jul 1, 2001 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 18, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: